İkinci basamakta pulmoner emboli tanısı

İkinci Basamak sağlık kuruluşunda pulmoner emboli tanısı konulabilir mi sorusuna cevap aramak amaçlanmıştır. Aralık 2007-Ekim 2008 tarihleri arasında Dörtyol Devlet hastanesi göğüs hastalıkları polikliniği ve acil servisine başvuran klinik skorlamada pulmoner emboli olasılığı yüksek olarak sınıflanan, yaş ortalaması 56±18, 6'sı erkek 19 olgu prospektif olarak değerlendirildi. Hastaların hepsine standart toraks BT, Alt ekstremite doppler USG ve arteryel kan gazı analizi yapıldı. Alveolo arteryel oksijen gradientleri hesaplandı.Başvuru sırasında en sık rastlanan semptom ve bulgular nefes darlığı %94.7 (n=18), bacakta şişlik, kızarıklık ve ağrı %84.2 (n=16) ile yanağrısı %57.9 (n=11) idi. Tromboemboliye zemin hazırlayan faktörler incelendiğinde 9 olguda immobilizasyon, 3 olguda obezite, 1 olguda pelvik operasyon, 1 olguda SLE'ye bağlı nefrotik sendrom, 1 olguda faktör V leiden eksikliği, 1 olguda da prostat malignitesi vardı. Tüm olguların alt ekstremite dopplerlerinde akut/subakut/kronik evre trombüs saptandı. A-a O2 gradienti tüm hastalarda artmıştı (ort: 52±40 mmHg). Olguların standart toraks bt'leri incelendiğinde 10 olguda (%52.6) BT'nin normal olduğu, 9 olguda da ise pulmoner emboli bulgularının saptandığı görüldü.Sonuç olarak, 2. basamak hastanelerde pulmoner emboli tanısı için klinik skorlama, doppler USG, standart toraks BT ve gradient hesaplaması rahatlıkla kullanılabilir.

Diagnosis of pulmonary embolism in secondary care

Finding a n answer of if the pulmoner embolism can be diagnosed in a secondary care health institution. 19 patients who were admitted to Dörtyol Public Hospital chest diseases polinic and emergency service in december 2007-october 2008 with diagnosed as high clinical probability of pulmonary embolism according to clinical scoring system were evaluated prospectively. 6 patients were men and mean age was 56±18. Standart thorax CT, lower limb doppler ultrasonography and blood gas analysis were applied to all patients. Alveoloarterial (A-a) oxygen gradient was calculated.Most frequent symptoms and signs were dyspnea 94.7% (n=18), leg swelling and pain 84.2% (n=16) and chest pain 57.9% (n=11). Patients risk factors for thromboembolism were immobilization (n=9), obesity (n=3), pelvic operation (n=1), nephrotic syndrome due to SLE (n=1), factor V Leiden deficiency and prostate cancer (n=1). Acute/ subacute/chronic phase thrombosis were established in all patients lower limb doppler ultrasonography. Alveolo-arterial gradient were increased in all patients. (mean 52±40). When we determined the torax CT findings 10 patients had normal and 9 patients had pulmonary embolism signs in torax CT.Pulmonary embolism can be diagnosed in second care hospitals clinical score system, doppler ultrasonography, standart torax CT and aveoloarterial gradient.

___

  • 1. Zellweger JP. Tobacco and tuberculosis. Monaldi Arch Chest Dis 2008; 69(2): 83-5.
  • 2. Chiang CY, Slama K, Enarson DA. Associations between tobacco and tuberculosis. Int J Tuberc Lung Dis 2007; 11: 258-62.
  • 3. Pai M, Mohan A, Dheda K, Leung CC, Yew WW, Christopher J, Sharma SK. Lethal interaction: the colliding epidemics of tobacco and tuberculosis. Expert Rev Anti Infect Ther 2007; 5: 385-91.
  • 4. Kolappan C, Gopi PG. Tobacco smoking and pulmonary tuberculosis. Thorax 2002; 57: 964-6.
  • 5. Hassmiller KM. The association between smoking and tuberculosis. Salud Publica Mex 2006; 48 Suppl 1: S 201-16.
  • 6. KšmŸß N, Albayrak S, Ellidokuz H, ‚ÝmrÝn AH. Mesleksel, ‚evresel maruziyetler ve akciÛer saÛlÝÛÝ ilißkisi. Tuberk Toraks 2008; 56: 275-82.
  • 7. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits. BMJ 1954, reprinted in BMJ 2002; 328: 1529Ð33.
  • 8. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: A sistematic review and meta-analysis. Arch Intern Med 2007; 167: 335-42.
  • 9. Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tubercolosis: A sistematic review and meta-analysis. PLoS Med 2007; 4: e20.
  • 10. Baran A, …zßeker F, MihmanlÝ A, AltÝnsoy B, DamadoÛlu E, ‚elik O, GŸngšr S, Akkaya E. TŸberkŸlozlu hastalarda hastaneye yatÝßÝn ve hastalÝk etkisinin sigara bÝrakma girißimine katkÝsÝ. Toraks DerneÛi, 7. YÝllÝk Kongresi, Antalya, 2004. (…zet)
  • 11. Brands A, Ottmani SE, Lonnroth K, et al. Reply to ÔAddressing smoking cessation in tuberculosis controlÕ. Bull World Health Organ 2007; 85: 647-8.
  • 12. Sony E, Slama K, Salieh M, Elhaj H, Adam K, Hassan A, Enarson DA. Feasibility of brief tobacco cessation advice for tuberculosis patients: a study from Sudan. Int J Tuberc Lung Dis 2007; 11:150Ð5.
  • 13. Slama K, Chiang CY, Enarson DA. Introducing brief advice in tuberculosis services. Int J Tuberc Lung Dis 2007; 11: 496-9.
  • 14. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, Enarson DA, Donald PR, Beyers N. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8: 392-402.
  • 15. Alcaide J, Altet M N, Plans P, Parr—n I, Folguera L, Salt— E, Dom’nguez A, Pardell H, Salleras L.. Cigarette smoking as a risk factor for tuberculosis in young adults: a case-control study. Tubercle Lung Dis 1996; 77: 112-6.
  • 16. Yu GP, Hsieh CC, Peng J. Risk factors associated with the prevalence of pulmonary tuberculosis among sanitary workers in Shanghai. Tubercle 1988; 69: 105-12.
  • 17. Altet-G—mez MN, Alcaide J, Godoy P, Romero MA, Hern‡ndez del Rey I. Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13,038 cases. Int J Tuberc Lung Dis 2005; 9: 430-6.
  • 18. Leung CC, Yew WW, Chan CK, et al. Smoking and tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2003; 7: 980Ð6.
  • 19. Bothamley GH. Smoking and tuberculosis: a chance or causal association? Thorax 2002; 57: 527-8.
  • 20. Leung CC, Li T, Lam TH, Yew WW, Law WS, Tam CM, Chan WM, Chan CK, Ho KS, Chang KC. Smoking and tuberculosis among the elderly in Hong Kong. Am J Respir Crit Care Med 2004; 170: 1027Ð33.
  • 21. Durban Immunotherapy Trial Group. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Lancet 1999; 354: 116Ð9.
  • 22. Balbay O, Annakkaya AN, Arbak P, Bilgin C, Erbas M. Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. Jpn J Infect Dis 2005; 58: 152-8.